SyntheticMR AB (publ)

SyntheticMR AB (publ) has a current ratio of 2.09, indicating that it has sufficient current assets to cover its current liabilities, but its operating cash flow is negative at -5.47 million SEK, and free cash flow is also negative at -51.05 million SEK, suggesting that the company is not generating positive cash from operations. The company's debt-to-equity ratio is 0.05, indicating a low level of leverage, and its long-term debt is 4.99 million SEK, which is relatively small compared to its total equity of 105.95 million SEK. The company's profitability is weak, with a return on equity of -51.84% and a return on assets of -39.9%, both significantly below the industry median for Advanced Medical Equipment & Technology. The net income is -54.93 million SEK, and the operating income is -49.31 million SEK, indicating that the company is not profitable and is experiencing significant operating losses. SyntheticMR AB (publ) operates in a single business segment focused on MRI software solutions, with no disclosed geographic revenue concentration. The company's revenue is derived from the sale of SyMRI software packages, including SyMRI IMAGE, SyMRI NEURO, and SyMRI Research Edition, which are marketed globally. The company's revenue for the latest period is 57.05 million SEK, but there is no disclosed growth trajectory or outlook for the next fiscal year. The company's operating cash flow and free cash flow are both negative, indicating that it is not generating sufficient cash to fund its operations or growth initiatives. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag is that the company has negative net cash after subtracting total debt, which could impact its ability to meet short-term obligations. The dilution risk is low, but the company's negative free cash flow and operating cash flow suggest that it may need to raise additional capital in the future, which could lead to share dilution. Recent events include the disclosure of financial results showing a net loss of 54.93 million SEK and a negative operating cash flow of 5.47 million SEK. The company has not disclosed any recent filings or transcripts that would indicate significant changes in its business strategy or financial position.